ارسل ملاحظاتك

ارسل ملاحظاتك لنا







How Novo Nordisk Used Porter’s Concept of Shared Value Achieving Profitable Business and Healthy Society: Professional Approach

المصدر: مجلة المالية وحوكمة الشركات
الناشر: جامعة العربي بن مهيدي أم البواقي - كلية العلوم الاقتصادية والعلوم التجارية وعلوم التسيير و مخبر الابتكار والهندسة المالية
المؤلف الرئيسي: Kherchi, Ishak (Author)
مؤلفين آخرين: Haddou, Samira Ahlem (Co-Author), Fellague, Mohamed (Co-Author)
المجلد/العدد: مج2, ع2
محكمة: نعم
الدولة: الجزائر
التاريخ الميلادي: 2018
الشهر: ديسمبر
الصفحات: 7 - 22
ISSN: 2602-5655
رقم MD: 1041747
نوع المحتوى: بحوث ومقالات
اللغة: الإنجليزية
قواعد المعلومات: EcoLink
مواضيع:
كلمات المؤلف المفتاحية:
Novo Nordisk | New Approach | Creating Shared Value | Social Value | Business Value
رابط المحتوى:
صورة الغلاف QR قانون

عدد مرات التحميل

4

حفظ في:
المستخلص: This paper aims to provide shared value as a new approach for pharmaceutical company to create social and economic value, in addition to that we aims to provide a theoretical background of the concept, then a practical contributions that ground understanding the concept of creating shared value. The authors analyse a single case study of Novo Nordisk. The objective is to show for professionals the importance of this new approach in creating social and economic value. We found that Novo Nordisk used this new approach of creating shared value by following set of social and economic programs; we also provide new approach of doing business for pharmaceutical companies. This single case study provides new approach to create social and economic value for pharmaceutical companies; however, more research is needed to find other approaches or testing the same approach in other industries. The paper has practical implications that relate to the design of shared value approach. We provide practical approach and ideas that could be applied by other companies to reach shared value creation professionals could use these ideas to create social and economic value. A professional unique approach to create social and economic value for pharmaceutical companies.

ISSN: 2602-5655